Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitochondrial redox signalling at a glance.
Collins Y, Chouchani ET, James AM, Menger KE, Cochemé HM, Murphy MP. Collins Y, et al. J Cell Sci. 2012 Feb 15;125(Pt 4):801-6. doi: 10.1242/jcs.098475. J Cell Sci. 2012. PMID: 22448036 No abstract available.
Mitochondrial oxidative stress and the metabolic syndrome.
James AM, Collins Y, Logan A, Murphy MP. James AM, et al. Among authors: collins y. Trends Endocrinol Metab. 2012 Sep;23(9):429-34. doi: 10.1016/j.tem.2012.06.008. Epub 2012 Jul 24. Trends Endocrinol Metab. 2012. PMID: 22831852
A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes.
Pun PB, Logan A, Darley-Usmar V, Chacko B, Johnson MS, Huang GW, Rogatti S, Prime TA, Methner C, Krieg T, Fearnley IM, Larsen L, Larsen DS, Menger KE, Collins Y, James AM, Kumar GD, Hartley RC, Smith RA, Murphy MP. Pun PB, et al. Among authors: collins y. Free Radic Biol Med. 2014 Feb;67(100):437-50. doi: 10.1016/j.freeradbiomed.2013.11.025. Epub 2013 Dec 4. Free Radic Biol Med. 2014. PMID: 24316194 Free PMC article.
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.
42 results